Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Jan 1996, 73-78, Vol 3, No. 1
L Kong, JG Smith, D Bramhill, GK Abruzzo, C Bonfiglio, C Cioffe, AM Flattery, CJ Gill, L Lynch, PM Scott, L Silver, C Thompson, H Kropp and K Bartizal
Although many detection methods have been used to determine Helicobacter
colonization in small animal models, the sensitivity and specificity of
these detection methods are limited. To improve the Helicobacter felis
conventional mouse model for accurate evaluation of therapeutic regimens,
we developed a PCR for detection of, and a competitive PCR for quantitation
of, H. felis in viral antibody-free (VAF) mice. The PCR was based on the H.
felis 16S rRNA gene. An internal control DNA was used for competitive
quantitation of the PCR. VAF conventional Swiss-Webster mice were infected
with an H. felis culture by oral gavage. At various times after H. felis
challenge and therapy, stomach mucosa was collected and evaluated by PCR.
PCR detected approximately 50 to 100 H. felis cells per mouse stomach and
showed no cross-reaction with other bacteria commonly found in mouse
stomachs. Colonization of H. felis in the mouse stomach was confirmed by
culture isolation from germfree mice and histological examination of VAF
mice. Response to therapy in this H. felis model correlated well with
results seen in human clinical trials with H. pylori. A model utilizing PCR
detection which may be useful for discovering new antibiotics and/or
vaccines against Helicobacter ulcer disease has been developed.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model
Department of Enzymology, Merck Research Laboratories, Merck and Co., Inc, Rahway, New Jersey 07065-0900, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |